Copyright Reports & Markets. All rights reserved.

Global Hip Osteoarthritis Pain Medicine Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Hip Osteoarthritis Pain Medicine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Hip Osteoarthritis Pain Medicine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Type
    • 1.4.2 Oral
    • 1.4.3 Injection
    • 1.4.4 External
  • 1.5 Market by Application
    • 1.5.1 Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Application
    • 1.5.2 Medical Care
    • 1.5.3 Personal Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Hip Osteoarthritis Pain Medicine Market Size, Estimates and Forecasts
    • 2.1.1 Global Hip Osteoarthritis Pain Medicine Revenue 2015-2026
    • 2.1.2 Global Hip Osteoarthritis Pain Medicine Sales 2015-2026
  • 2.2 Global Hip Osteoarthritis Pain Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hip Osteoarthritis Pain Medicine Competitor Landscape by Players

  • 3.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers
    • 3.1.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers (2015-2020)
    • 3.1.2 Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Hip Osteoarthritis Pain Medicine Revenue by Manufacturers
    • 3.2.1 Hip Osteoarthritis Pain Medicine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Hip Osteoarthritis Pain Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Hip Osteoarthritis Pain Medicine Revenue in 2019
    • 3.2.5 Global Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Hip Osteoarthritis Pain Medicine Price by Manufacturers
  • 3.4 Hip Osteoarthritis Pain Medicine Manufacturing Base Distribution, Product Types
    • 3.4.1 Hip Osteoarthritis Pain Medicine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Hip Osteoarthritis Pain Medicine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Hip Osteoarthritis Pain Medicine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Hip Osteoarthritis Pain Medicine Market Size by Type (2015-2020)
    • 4.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020)
    • 4.1.2 Global Hip Osteoarthritis Pain Medicine Revenue by Type (2015-2020)
    • 4.1.3 Hip Osteoarthritis Pain Medicine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Hip Osteoarthritis Pain Medicine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Hip Osteoarthritis Pain Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Hip Osteoarthritis Pain Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Hip Osteoarthritis Pain Medicine Market Size by Application (2015-2020)
    • 5.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020)
    • 5.1.2 Global Hip Osteoarthritis Pain Medicine Revenue by Application (2015-2020)
    • 5.1.3 Hip Osteoarthritis Pain Medicine Price by Application (2015-2020)
  • 5.2 Hip Osteoarthritis Pain Medicine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Hip Osteoarthritis Pain Medicine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Hip Osteoarthritis Pain Medicine by Country
    • 6.1.1 North America Hip Osteoarthritis Pain Medicine Sales by Country
    • 6.1.2 North America Hip Osteoarthritis Pain Medicine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
  • 6.3 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Hip Osteoarthritis Pain Medicine by Country
    • 7.1.1 Europe Hip Osteoarthritis Pain Medicine Sales by Country
    • 7.1.2 Europe Hip Osteoarthritis Pain Medicine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
  • 7.3 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Hip Osteoarthritis Pain Medicine by Region
    • 8.1.1 Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region
    • 8.1.2 Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
  • 8.3 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Hip Osteoarthritis Pain Medicine by Country
    • 9.1.1 Latin America Hip Osteoarthritis Pain Medicine Sales by Country
    • 9.1.2 Latin America Hip Osteoarthritis Pain Medicine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
  • 9.3 Central & South America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Hip Osteoarthritis Pain Medicine by Country
    • 10.1.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country
    • 10.1.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Hip Osteoarthritis Pain Medicine Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 Johnson and Johnson
    • 11.2.1 Johnson and Johnson Corporation Information
    • 11.2.2 Johnson and Johnson Description and Business Overview
    • 11.2.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Johnson and Johnson Hip Osteoarthritis Pain Medicine Products Offered
    • 11.2.5 Johnson and Johnson Related Developments
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Corporation Information
    • 11.3.2 GlaxoSmithKline Description and Business Overview
    • 11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Products Offered
    • 11.3.5 GlaxoSmithKline Related Developments
  • 11.4 Bayer
    • 11.4.1 Bayer Corporation Information
    • 11.4.2 Bayer Description and Business Overview
    • 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Bayer Hip Osteoarthritis Pain Medicine Products Offered
    • 11.4.5 Bayer Related Developments
  • 11.5 Eli Lilly
    • 11.5.1 Eli Lilly Corporation Information
    • 11.5.2 Eli Lilly Description and Business Overview
    • 11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Eli Lilly Hip Osteoarthritis Pain Medicine Products Offered
    • 11.5.5 Eli Lilly Related Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description and Business Overview
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Hip Osteoarthritis Pain Medicine Products Offered
    • 11.6.5 Novartis Related Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Corporation Information
    • 11.7.2 Sanofi Description and Business Overview
    • 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanofi Hip Osteoarthritis Pain Medicine Products Offered
    • 11.7.5 Sanofi Related Developments
  • 11.8 Horizon Pharma
    • 11.8.1 Horizon Pharma Corporation Information
    • 11.8.2 Horizon Pharma Description and Business Overview
    • 11.8.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Horizon Pharma Hip Osteoarthritis Pain Medicine Products Offered
    • 11.8.5 Horizon Pharma Related Developments
  • 11.9 Abbott
    • 11.9.1 Abbott Corporation Information
    • 11.9.2 Abbott Description and Business Overview
    • 11.9.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Abbott Hip Osteoarthritis Pain Medicine Products Offered
    • 11.9.5 Abbott Related Developments
  • 11.10 Mylan
    • 11.10.1 Mylan Corporation Information
    • 11.10.2 Mylan Description and Business Overview
    • 11.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Mylan Hip Osteoarthritis Pain Medicine Products Offered
    • 11.10.5 Mylan Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Hip Osteoarthritis Pain Medicine Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.12 TEVA
    • 11.12.1 TEVA Corporation Information
    • 11.12.2 TEVA Description and Business Overview
    • 11.12.3 TEVA Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 TEVA Products Offered
    • 11.12.5 TEVA Related Developments
  • 11.13 Almatica Pharma
    • 11.13.1 Almatica Pharma Corporation Information
    • 11.13.2 Almatica Pharma Description and Business Overview
    • 11.13.3 Almatica Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Almatica Pharma Products Offered
    • 11.13.5 Almatica Pharma Related Developments
  • 11.14 Astellas Pharma
    • 11.14.1 Astellas Pharma Corporation Information
    • 11.14.2 Astellas Pharma Description and Business Overview
    • 11.14.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Astellas Pharma Products Offered
    • 11.14.5 Astellas Pharma Related Developments
  • 11.15 Tide Pharmaceutical
    • 11.15.1 Tide Pharmaceutical Corporation Information
    • 11.15.2 Tide Pharmaceutical Description and Business Overview
    • 11.15.3 Tide Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Tide Pharmaceutical Products Offered
    • 11.15.5 Tide Pharmaceutical Related Developments
  • 11.16 Iroko Pharmaceuticals
    • 11.16.1 Iroko Pharmaceuticals Corporation Information
    • 11.16.2 Iroko Pharmaceuticals Description and Business Overview
    • 11.16.3 Iroko Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Iroko Pharmaceuticals Products Offered
    • 11.16.5 Iroko Pharmaceuticals Related Developments
  • 11.17 Hengrui Pharmaceutical
    • 11.17.1 Hengrui Pharmaceutical Corporation Information
    • 11.17.2 Hengrui Pharmaceutical Description and Business Overview
    • 11.17.3 Hengrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Hengrui Pharmaceutical Products Offered
    • 11.17.5 Hengrui Pharmaceutical Related Developments
  • 11.18 Abiogen Pharma
    • 11.18.1 Abiogen Pharma Corporation Information
    • 11.18.2 Abiogen Pharma Description and Business Overview
    • 11.18.3 Abiogen Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Abiogen Pharma Products Offered
    • 11.18.5 Abiogen Pharma Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Hip Osteoarthritis Pain Medicine Market Estimates and Projections by Region
    • 12.1.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
    • 12.2.2 North America: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Hip Osteoarthritis Pain Medicine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Hip Osteoarthritis Pain Medicine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Hip Osteoarthritis Pain Medicine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Hip Osteoarthritis Pain Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hip Osteoarthritis Pain Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Hip Osteoarthritis Pain Medicine market is segmented into
    Oral
    Injection
    External

    Segment by Application, the Hip Osteoarthritis Pain Medicine market is segmented into
    Medical Care
    Personal Care

    Regional and Country-level Analysis
    The Hip Osteoarthritis Pain Medicine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Hip Osteoarthritis Pain Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Hip Osteoarthritis Pain Medicine Market Share Analysis
    Hip Osteoarthritis Pain Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hip Osteoarthritis Pain Medicine business, the date to enter into the Hip Osteoarthritis Pain Medicine market, Hip Osteoarthritis Pain Medicine product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    Johnson and Johnson
    GlaxoSmithKline
    Bayer
    Eli Lilly
    Novartis
    Sanofi
    Horizon Pharma
    Abbott
    Mylan
    Daiichi Sankyo
    TEVA
    Almatica Pharma
    Astellas Pharma
    Tide Pharmaceutical
    Iroko Pharmaceuticals
    Hengrui Pharmaceutical
    Abiogen Pharma

    Buy now